Funding for this research was provided by:
KWF Kankerbestrijding (10674)
Received: 25 May 2021
Accepted: 10 November 2021
First Online: 4 December 2021
: This SPARC study has been approved by the Medical Ethical Committee Leiden-Den Haag-Delft (number NL62767.058.17) and by the institutional review boards of the 10 participating gynaecological cancer centres (see the Acknowledgements section). Participating women have provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.